Showing results (241-250 of 543) with videos related to
Sort By:
Pageof 55
Human Vaccines & Immunotherapeutics|April 28, 2026
Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) networkMarina Viñeta Paramo, Marilou Kiely, Louis Valiquette, et al.Plos One|July 24, 2008
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South AmericaRoss J Davidson, Ian Davis, Barbara M Willey, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2012
Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, CanadaSergio Borgia, Olga Lastovetska, David Richardson, et al.Trials|March 23, 2021
Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trialDarrell H S Tan, Adrienne K Chan, Peter Jüni, et al.Journal of the American Chemical Society|September 29, 2022
Capillary-Assisted Molecular Pendulum BioanalysisHossein Zargartalebi, Hanie Yousefi, Connor D Flynn, et al.The European Respiratory Journal|November 5, 2016
Laboratory diagnosis of pneumonia in the molecular ageAntoni Torres, Nelson Lee, Catia Cilloniz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2010
Epidemic of group A Streptococcus M/emm59 causing invasive disease in CanadaGregory J Tyrrell, Marguerite Lovgren, Theresa St Jean, et al.American Journal of Infection Control|August 21, 2012
Measuring influenza immunization coverage among health care workers in acute care hospitals and continuing care organizations in CanadaSusan Quach, Jennifer A Pereira, Jemila S Hamid, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2021
Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program-Ontario, Canada, April-May 2021Chantal Williams, Dana Al-Bargash, Celeste Macalintal, et al.Human Vaccines & Immunotherapeutics|April 29, 2026
Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) networkCailey Turner, Otto G Vanderkooi, James D Kellner, et al.Pageof 55